KANSAS CITY, Mo. & ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Cerner Corporation (NASDAQ: CERN), the University of New Mexico Health Sciences Center (UNMHSC) College of Pharmacy, the UNM School of Engineering and STC.UNM (STC), the University’s technology-transfer corporation, announced today the signing of a Sponsored Research Agreement to evaluate UNMHSC’s dry-powder inhaler (DPI) drug-delivery technology for use in both pulmonary and systemic conditions, like asthma and chronic obstructive lung disease. Upon completion of the research studies, the agreement provides Cerner an option for exclusive licensing of UNMHSC’s technology for clinical and commercial use worldwide.
